AstraZeneca shares gain on speculation of new Pfizer bid

LONDON (Reuters) - AstraZeneca shares gained 2 percent in early trading on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.